Published On: May 9, 2023Categories: Podcast
Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinical efficacy, advantages, and impact on patient quality of life of utilising Bruton’s tyrosine kinase inhibitors for the treatment of CSU, along with further discussion of alternative treatments. Access additional resources by signing up to Medthority and to be notified for future ‘All Things Urticaria’ podcast episodes!
Do you have suggestions for future episodes?  Please reach out to us via  email or fill out this form here and offer your suggestions for future topics and expert selection!

Read more news regarding urticaria

  • News

    April 15, 2024

    With 85 episodes, our podcast all Things Urticaria has reached 30.000 downloads! Listen to all episodes here: SPOTIFY APPLE PODCAST

  • New centers,News

    April 12, 2024

    On March 28, Marcus Mauer had the great privilege to perform a triple re-audit for  UCARE, ACARE and ADCARE  at the Peking University First Hospital Center in Beijing, China. [...]

  • New centers,News

    April 12, 2024

    A very warm welcome to our newest UCARE (and ACARE) Center in Spain: Hospital General Universitario Gregorio Marañón Allergy Department Head: Dr. Ana Entrala Bueso Deputy: Dr. María Luisa Baeza [...]